VYNE Therapeutics (VYNE) - 2023 Q4 - Annual Results

Exhibit 99.1 VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update BRIDGEWATER, N.J., February 29, 2024 -- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company"), a clinical- stage biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced financial results for the fourth quarter and year ended December 31, 2023 and provided a business update. "We hav ...